Search
Hong Kong's Innovative Drug Sector Strengthens, with Ascletis Pharma Soaring Over 20%
2025-04-22 /
Read about 0 minute
Author：小编
Hong Kong's innovative drug sector has shown significant strengthening, with Ascletis Pharma-B surging over 20%. Rongchang Biology and CSPC Pharmaceutical Group also recorded gains of over 6%, while BeiGene and Innovent Biologics, among others, followed suit.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
